New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells

Journal of Molecular Histology

Volumn 35, Issue 3, 2004, Pages 319-326

  Han, Innoc ^a   Park, Haein ^b   Oh, Eok Soo ^b  

^a National Cancer Center   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; SYNDECAN 2; MEMBRANE PROTEIN; PROTEOGLYCAN; SDC2 PROTEIN, HUMAN;

CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CARCINOGENESIS; CARCINOMA CELL; CELL ACTIVITY; CELL ADHESION; CELL DIVISION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURFACE; COLON CARCINOMA; CORRELATION ANALYSIS; CYTOPLASM; CYTOSKELETON; DISEASE ACTIVITY; DISEASE MARKER; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR GENETICS; MOLECULAR MECHANICS; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; ADENOCARCINOMA; ANIMAL; CELL TRANSFORMATION; COLON TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS; SYNDECAN-2;

EID: 14844287100     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:HIJO.0000032363.78829.4e     Document Type: Review

References (79)

1. American Cancer Society (2003) Cancer Facts and Figures 2003 Atlanta, GA: American Cancer Society.
2. Anttonen A, Heikkila P, Kajanti M, Jalkanen M, Joensuu H (2001) High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 32: 297-305.
3. Bass MD, Humphries MJ (2002) Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signaling. Biochem J 368: 1-15.
4. Bayer-Garner IB, Smoller BR (2001) The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol 28: 83-89.
5. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ (1992) Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8: 365-393.
6. Boudreau N, Bissell MJ (1998) Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646.
7. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R (2002) Integrins in invasive growth. J Clin Invest 109: 999-1006.
8. Carey DJ (1997) Syndecans: Multifunctional cell-surface co-receptors. Biochem J 327: 1-16.
9. Chung DC (2000) The genetic basis of colorectal cancer: Insights into critical pathways of tumourigenesis. Gastroenterology 119: 854-865.
10. Chung DC, Rustgi AK (2003) The hereditary nonpolyposis colorectal cancer syndrome: Genetics and clinical implications. Ann Int Med 138: 560-570.
11. Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H, Buchler MW (2000) Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 88: 12-20.
12. Contreras HR, Fabre M, Granes F, Casaroli-Marano R, Rocamora N, Herreros AG, Reina M, Vilaro S (2001) Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype. Biochem Biophys Res Commun 286: 742-751.
13. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H (1993) Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 119: 841-854.
14. Ethell IM, Yamaguchi Y (1999) Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J Cell Biol 144: 575-586.
15. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M (2001) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metallo-proteinase. J Cell Biol 148: 811-824.
16. Fornaro M, Tallini G, Bofetiado CJ, Bosari S, Languino LR (1996) Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol 149: 765-773.
17. Gao Y, Li M, Chen W, Simons M (2000) Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol 184: 373-379.
18. Granes F, Garcia R, Casaroli-Marano RP, Castel S, Rocamora N, Reina M, Urena JM, Vilaro S (1999) Syndecan-2 induces filopodia by active cdc42Hs. Exp Cell Res 248: 439-456.
19. Granes F, Urena JM, Rocamora N, Vilaro S (2000) Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci 113: 1267-1276.
20. Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J, David G (1997) Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 94: 13683-13688.
21. Guarino M, Micheli P, Pallotti F, Giordano F (1999) Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol Res Pract 195: 379-389.
22. Gumbiner BM (1996) Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357.
23. Hazan RB, Kang L, Whooley BP, Borgen PI (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399-411.
24. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
25. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S, Beppu T (1994) Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 214: 189-197.
26. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M (1997) Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 430: 285-289.
27. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
28. Inki P, Stenback F, Grenman S, Jalkanen M (1994) Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 172: 349-355.
29. Jayson GC, Vives C, Paraskeva C, Schofield K, Coutts J, Fleetwood A, Gallagher JT (1999) Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer 82: 298-304.
30. Joensuu H, Anttonen A, Eriksson M, Makitaro R, Alfthan H, Kinnula V, Leppa S (2002) Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 62: 5210-5217.
31. Kim Y, Park H, Lim Y, Han I, Kwon HJ, Woods A, Oh ES (2003) Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumourigenic activity in colon carcinoma cells. Oncogene 22: 826-830.
32. Klass CM, Couchman JR, Woods A (2000) Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci 113: 493-506.
33. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH (2002) Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 21: 4080-4088.
34. Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M (2000) Participation of syndecan 2 in the induction of stress fibre formation in cooperation with integrin alpha5beta1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res 256: 434-444.
35. Kwon HJ, Owa T, Hassig CA, Shimada J, Schreiber SL (1998) Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci USA 95: 356-361.
36. Leppa S, Mali M, Miettinen HM, Jalkanen M (1992) Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumour cells. Proc Natl Acad Sci USA 89: 932-936.
37. Liebersbach BF, Sanderson RD (1994) Expression of syndecan-1 inhibits cell invasion into type I collagen expression of syndecan-1 inhibits cell invasion into collagen and that loss of syndecan-1 expression may be necessary prior to the migration of normal or metastatic cells. J Biol Chem 269: 20013-22019.
38. Lim Y, Han I, Kwon HJ, Oh ES (2002) Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. J Biol Chem 277: 12735-12740.
39. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411: 375-379.
40. Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, Sanderson RD (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem 273: 22825-22832.
41. Longhurst CM, Jennings LK (1998) Integrin-mediated signal transduction. Cell Mol Life Sci 54: 514-526.
42. Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, Couchman JR (1999) Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci 112: 3421-3431.
43. Mali M, Andtfolk H, Miettinen HM, Jalkanen M (1994) Suppression of tumour cell growth by syndecan-1 ectodomain. J Biol Chem 269: 27795-27798.
44. Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD, Korc M (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61: 5562-5569.
45. Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M, Kohgo Y (1997) Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74: 482-489.
46. Mercurio AM, Rabinovitz I (2001) Towards a mechanistic understanding of tumour invasion - lessons from the alpha6beta 4 integrin. Semin Cancer Biol 11: 129-141.
47. Modrowski D, Basle M, Lomri A, Marie PJ (2000) Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J Biol Chem 275: 9178-9185.
48. Mulder JW, Wielenga VJ, Pals ST, Offerhaus GJ (1997) p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis. Histochem J 29: 439-452.
49. Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M (2002) The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem J 363: 201-209.
50. Nanki N, Fujita J, Yang Y, Hojo S, Bandoh S, Yamaji Y, Ishida T (2001) Expression of oncofetal fibronectin and syndecan-1 mRNA in 18 human lung cancer cell lines. Tumour Biol 22: 390-396.
51. Numa F, Hirabayashi K, Kawasaki K, Sakaguchi Y, Sugino N, Suehiro Y, Suminami Y, Hirakawa H, Umayahara K, Nawata S, Ogata H, Kato H (2002) Syndecan-1 expression in cancer of the uterine cervix: Association with lymph node metastasis. Int J Oncol 20: 39-43.
52. Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR (1998) Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem 273: 10624-10629.
53. Okegawa T, Li Y, Pong RC, Hsieh JT (2002) Cell adhesion proteins as tumour suppressors. J Urol 167: 1836-1843.
54. Park H, Kim Y, Lim Y, Han I, Oh ES (2002) Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem 277: 29730-29736.
55. Park PW, Pier GB, Hinkes MT, Bernfield M (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411: 98-102.
56. Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF (2001) E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 85: 1958-1963.
57. Pawlak G, Helfman DM (2001) Cytoskeletal changes in cell transformation and tumourigenesis. Curr Opin Genet Dev 11: 41-47.
58. Penna C, Nordlinger B (2003) Surgery and local treatments of liver metastases from colorectal cancer: How to improve results. Scand J Surg 92: 90-96.
59. Piard F, Chapusot C, Ecarnot-Laubriet A, Ponnelle T, Martin L (2002) Molecular markers of heterogeneity in colorectal cancers and adenomas. Eur J Cancer Prev 11: 85-97.
60. Pupa SM, Menard S, Forti S, Tagliabue E (2002) New insights into the role of extracellular matrix during tumour onset and progression. J Cell Physiol 192: 259-267.
61. Rapraeger AC (2000) Syndecan-regulated receptor signaling. J Cell Biol 149: 995-998.
62. Rapraeger AC (2001) Molecular interactions of syndecans during development. Semin Cell Dev Biol 12: 107-116.
63. Rintala M, Inki P, Klemi P, Jalkanen M, Grenman S (1999) Association of syndecan-1 with tumour grade and histology in primary invasive cervical carcinoma. Gynecol Oncol 75: 372-378.
64. Simons M, Horowitz A (2001) Syndecan-4-mediated signaling. Cell Signal 13: 855-862.
65. Skubitz AP (2002) Adhesion molecules. Cancer Treat Res 107: 305-329.
66. Soukka T, Pohjola J, Inki P, Happonen RP (2000) Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 29: 308-313.
67. Stanley MJ, Stanley MW, Sanderson RD, Zera R (1999) Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 112: 377-383.
68. Subramanian SV, Fitzgerald ML, Bernfield M (1997) Regulated shedding of syndecans-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272: 14713-14720.
69. Suzuki K, Takahashi K (1999) Reduced substratum adhesion and decreased expressions of 1 and 4 integrins in human breast cancer cells with a property of anchorage-independent growth. Int J Oncol 14: 897-904.
70. Troyanovsky SM (1999) Mechanism of cell-cell adhesion complex assembly. Curr Opin Cell Biol 11: 561-566.
71. Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C (2001) Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95: 1-6.
72. Woods A, Couchman JR (1994) Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5: 183-192.
73. Woods A, Couchman JR (2001) Syndecan-4 and focal adhesion function. Curr Opin Cell Biol 13: 578-583.
74. Woods A, Oh ES, Couchman JR (1998) Syndecan proteoglycans and cell adhesion. Matrix Biol 17: 477-483.
75. Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, Sanderson RD (2002) Soluble syndecan-1 promotes growth of myeloma tumours in vivo. expressing soluble syndecan-1 are hyperinvasive in collagen gels relative to controls. Blood 100: 610-617.
76. Yoshida M, Kijima M, Akita M, Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179.
77. Yu Q, Stamenkovi I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumour invasion and angiogenesis. Genes Dev 14: 163-176.
78. Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L (2003) Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 55: 20-29.
79. Zimmermann P, David G (1999) The syndecans, tuners of transmembrane signaling. FASEB J 13: S91-S100.